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Predictors of lost to follow-up in a “test and
treat” programme among adult women
with high-risk sexual behavior in Kampala,
Uganda
Onesmus Kamacooko1* , Yunia Mayanja1, Daniel Bagiire1, Gertrude Namale1, Christian Holm Hansen1,2 and
Janet Seeley1,2
Abstract
Background: Immediate uptake of antiretroviral therapy (ART) after an HIV-positive diagnosis (Test and Treat) is
now being implemented in Uganda. Data are limited on lost to follow-up (LTFU) in high-risk cohorts that have
initiated ‘Test and Treat’. We describe LTFU in a cohort of women of high-risk sexual behaviour who initiated ART
under “Test and Treat”.
Methods: We performed a retrospective cohort study of participant records at the Good Health for Women Project
(GHWP) clinic, a clinic in Kampala for women at high-risk of HIV-infection. We included HIV positive women ≥18
years who initiated ART at GHWP between August 2014 and March 2018. We defined LTFU as not taking an ART
refill for ≥3 months from the last clinic appointment among those not registered as dead or transferred to another
clinic. We used the Kaplan-Meier technique to estimate time to LTFU after ART initiation. Predictors of LTFU were
assessed using a multivariable Cox proportional hazards model.
Results: The mean (±SD) age of the 293 study participants was 30.3 (± 6.5) years, with 274 (94%) reporting paid sex
while 38 (13%) had never tested for HIV before enrolment into GHWP. LTFU within the first year of ART initiation was
16% and the incidence of LTFU was estimated at 12.7 per 100 person-years (95%CI 9.90–16.3). In multivariable analysis,
participants who reported sex work as their main job at ART initiation (Adjusted Hazards Ratio [aHR] =1.95, 95%CI 1.10–
3.45), having baseline WHO clinical stage III or IV (aHR = 2.75, 95% CI 1.30–5.79) were more likely to be LTFU.
Conclusion: LTFU in this cohort is high. Follow up strategies are required to support women on Test and Treat to
remain on treatment, especially those who engage in sex work and those who initiate ART at a later stage of disease.
Keywords: Universal test and treat, Women at high-risk, Lost to follow-up, Loss to follow-up; sub-Saharan Africa
Background
It is estimated that by the end of 2018, 23.3 million people
were receiving antiretroviral therapy (ART) globally and
that between 2000 and 2018, HIV-related deaths fell by
45% with 13.6 million lives saved due to ART in the same
period [1]. In sub-Saharan Africa (SSA) access to ART has
improved from 10.3 million people in 2015 to 12.9 million
people by the end of 2018 [2]. In Uganda, by the end of
2018, it was estimated that 1.4 million people were living
with HIV of whom 73% were on ART and an estimated
23,000 Ugandans had died of HIV-related illnesses [1]. In
Uganda, the general population HIV prevalence has
© The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.
* Correspondence: Onesmus.Kamacooko@mrcuganda.org
1MRC/UVRI & LSHTM Uganda Research Unit, Plot 51-59 Nakiwogo Road, P. O
Box 49, Entebbe, Uganda
Full list of author information is available at the end of the article
Kamacooko et al. BMC Public Health          (2020) 20:353 
https://doi.org/10.1186/s12889-020-8439-9
stabilised at 6% [3] while the prevalence among key popu-
lations (such as female sex workers [FSW]) is estimated to
be over 30% [4]. Studies have shown that ART is not only
improving quality of life and decreasing morbidity in those
receiving treatment but that the public health impact of
scaling up ART may contribute significantly to prevention
efforts [5, 6]. Recent studies have shown that early ART
initiation reduced transmission of HIV and that there is
great potential of treatment for prevention [6–8]. Given
that the risk of HIV infections is high for key populations
[9], this scale-up in ART is particularly important to
maximize the effectiveness of treatment as prevention in
such populations [10]. The scale up among key popula-
tions may have an impact on the HIV epidemic, since it is
estimated that in SSA they contribute between 7 and 30%
of new infections [11, 12].
The scale-up of treatment can only be effective if
people living with HIV remain on treatment following
diagnosis and ART initiation, but retention in care re-
mains a challenge in both high and low income settings
[13]. With the current efforts aimed at initiating all
HIV-positive individuals on immediate ART, regardless
of CD4 and WHO clinical stage, in an approach called
“Test and Treat” [14], retention in care is key if the full
potential is to be realised including achieving the 90–90-
90 targets especially the 3rd 90 which is the one mostly
affected by retention [15].
Treatment has become more widely available, but few
data have been published on rates of retention and predic-
tors of loss to follow-up (LTFU) among people at high-
risk of HIV-infection enrolled on immediate ART. Studies
carried out in the general population have shown that
LTFU ranged between 14 and 18% for the people living
with HIV initiated on ART with some studies indicating
that 41% of the LTFU occurred within the first 6 months
of ART initiation [16–18]. We build on this work with a
cohort of HIV positive women who started ART in a “Test
and Treat” facility in Kampala, Uganda during the period
of August 2014 to March 2018. We estimated the rate of
LTFU and associated factors/predictors.
Methods
Study design
We performed a retrospective cohort study among
women at high-risk of HIV infection, on ART, using re-
cords between August 2014 and March 2018.
Study population and setting
This study was embedded within an existing cohort of
women living with HIV, or at high risk of HIV infection,
attending the Good Health for Women Project (GHWP)
clinic in Kampala. The GHWP clinic was established in a
peri-urban community in southern Kampala in 2008
under the then Medical Research Council/Uganda Virus
Research Institute (MRC/UVRI), Uganda Research Unit
on AIDS to study the epidemiology of HIV and sexually
transmitted infections (STIs) and to implement HIV/STI
prevention among high-risk women. Women attending
the clinic engage in risky sexual behaviours such as sex
with men for money, goods or favours; recruitment of
women from commercial-sex hotspots has been described
elsewhere [4]. All women were screened for eligibility and
gave written consent before being enrolled in GHWP. Eli-
gible women are then enrolled in the GHWP clinic irre-
spective of HIV status. The clinic offers routine HIV
counselling and testing, syndromic management of STIs,
family planning, antenatal care, free condoms, risk reduc-
tion counselling, counselling for excessive alcohol use, TB
screening and treatment, ART and co-trimoxazole /dap-
sone preventive therapy. Enrolled women attend quarterly
visits for HIV prevention and treatment services.
In August 2014, the GHWP clinic started the “test and
treat” in accordance with new ART guidelines [19],
which mandated that all people living with HIV should
be initiated on ART irrespective of CD4 T-cell count
and WHO clinical staging, as long as they were willing
and ready to start treatment.
Eligibility criteria
All HIV positive women who initiated immediate ART
at the clinic were eligible for screening into this study.
Participants were included in this study if they met the
following eligibility criteria: HIV positive women ≥18
years and initiated ART between August 2014 and
March 2018.
Definition of study variables
High-risk
Women were classified as being at high-risk of HIV-
infection if they were earning their living by exchanging
sex for money, goods or other favors in lodges, on the
street and around entertainment places. Women were
also classified as being at high risk if they were illicit
drug users, alcohol dependent and employed in enter-
tainment facilities (for instance as waitress, massage
attendants or entertainers/singers) where they may ex-
change sex for money after working hours, in order to
supplement their income.
Study outcome
The study outcome was Lost to Follow-Up (LTFU)
which we defined as not collecting ART refill for 3
months or longer from the last clinic appointment and
not classified as dead or transferred for care to another
clinic [20]. Women who had died or transferred their
care to another clinic were censored at the time of their
last visit and were not considered LTFU. The time to
LTFU was calculated in months as the time interval
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between the date of ART initiation to the date of drop
out (from ART initiation to first 3-month drop out), as
recorded in the clinic ART database. All participants
were followed until March 2018 unless they were LTFU,
or had transferred or died before then.
Independent variables
Baseline characteristics at ART start were considered for
this analysis. The sociodemographic characteristics con-
sidered were: participant’s age at ART initiation, marital
status, highest level of education attained, current job, be-
havioural characteristics were; ever being involved in paid
sex, alcohol consumption patterns were assessed by using
the Alcohol Use Disorders Identification Test (AUDIT)
questionnaire which is a standardised tool developed by
WHO. It consists of 10 questions to assess alcohol use dis-
orders in the past 12months [21], and, Clinical character-
istics included: baseline WHO clinical stage, baseline CD4
cell count (cells/μl), year of ART start and ever tested for
HIV before enrolling at the clinic.
ART start and follow-up procedures
The GHWP clinic staff gave information sessions about
the ‘Test and Treat’ guidelines to women and the benefits
to their health and the wider community. Women were
also taught and counselled on disclosure, drug reactions,
the importance of treatment adherence, and then indi-
vidually assessed for readiness to start ART using the
Ministry of Health (MoH) ART readiness assessment
form [19]. Using the MoH ART guidelines, the initial
ART prescriptions were for 2 weeks, then 1 month
followed by an evaluation to check for any ART side ef-
fects, and then three-monthly ART refills. Attending an
ART refill visit entailed visiting the clinic, seeing a phys-
ician, and receiving counselling before getting drugs from
the pharmacy. First-line ART regimens dispensed at the
clinic combined two nucleoside reverse transcriptase in-
hibitors (Tenofovir or Zidovudine and Lamivudine or
Emtricitabine) and one non-nucleoside reverse transcript-
ase inhibitor (Nevirapine or Efavirenz).
Follow up strategies for ART participants
The pharmacist generates the list of women expected to
come for ART refill. On a weekly basis, the field team
follows up the clients (makes reminder calls) i.e. phone
calling and physical visits either at home or at their
places of work (hotspots) reminding them of their pend-
ing appointments.
In situations where the client has no telephone contact
or their phone is unavailable, the field worker contacts a
peer educator to pass over the information to the respect-
ive client/s. In case, the client misses the appointment and
there is no documented reason for missing (reasons like
travelled to the village, or to the islands, abroad etc.), then
the field worker retrieves the locator form for such client
and try to look for her physically, sometimes with the help
of the peer educator or an influential person at the hot-
spot e.g. the lodge manager. When found, the field worker
encourages such client to come and finds out the reasons
for missing the appointment. The process continues until
the client is located and encouraged to attend or declared
lost to follow up.
Sources of data
Data were collected as part of routine clinical care moni-
toring and for research purposes within the clinic. Data
entered in the clinic database (MS Access, Microsoft, Se-
attle, CA, USA) captured sociodemographic, alcohol use
and sexual behaviour, clinical and reproductive health
characteristics. HIV monitoring data such as HIV test
results and all ART data were entered in an OpenMRS
version 1.6.3 database which was merged with the
GHWP database. Data were collected during one-on-
one private sessions held in clinic rooms with trained
GHWP clinic counsellors. The pharmacy team captured
data on ART refill dates, duration on ART, last ART re-
fill dates and prescriptions. HIV antibody test results
were recorded on laboratory source documents by la-
boratory staff while CD4 results were generated as print-
outs and entered manually into the OpenMRS database.
Statistical analysis
The MS Access and OpenMRS databases were merged
into one database, cleaned, and exported to STATA 15.0
(StataCorp, College Station, TX, USA) for analysis. The
participants’ characteristics were summarised in descrip-
tive terms such as mean, median, standard deviations
(SD) or percentage, as appropriate. We used the Kaplan-
Meier technique to estimate time to LTFU after ART
initiation and present the estimated LTFU rates per 100
person-years for the study variables. LTFU rate was
assessed within the first year of follow-up. Cox propor-
tional hazards regression was used to determine inde-
pendent predictors of LTFU among participants and
these were expressed as estimated hazard ratios (HRs)
with their corresponding 95% confidence intervals (CIs).
In the bivariate proportional hazards analysis, variables
which gave a Likelihood Ratio Test (LRT) p-value less
than 0.25 were subsequently considered for the adjusted
model. In adjusted modelling, variables whose p-value
was less than 0.05 were considered independent predic-
tors of LTFU. We tested the validity of the overall model
assumption by running a global test of the proportional-
hazards assumption after fitting the model. We consid-
ered age at ART initiation and prior HIV testing a priori
confounders; these were included in the multivariable
model regardless of their unadjusted p values.
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We further compared those who started ART at GHWP
and those who did not to see if there were significant dif-
ferences between the two groups in terms of the selected
socio-demographic and clinical characteristics.
Sensitivity analyses
We conducted sensitivity analyses to address the issue of
missing data on selected covariates. Participants who
had missing data on some covariates were imputed using
multivariate imputation by chained equations approach
[22]. A sample of missing values were created, condi-
tional on the distribution of the remaining covariates in
the adjusted model. We assumed that the data were
missing at random and carried out 10 rounds of multiple
imputations; the final data for analysis after imputation
were combined using Rubin’s rule [23]. We compared
the results from the complete case analysis and those
from the imputed model.
Ethical considerations
The Uganda National Council for Science and Technol-
ogy (HS 364) and Uganda Virus Research Institute-
Research Ethics Committee approved the study. Writ-
ten informed consent was obtained from all partici-
pants. Data were de-identified prior to analysis of the
numerical identifiers that were used during the data
collection.
Results
Between August 2014 and March 2018, 3062 participants
were cumulatively registered with GHWP of whom 1062
were HIV-positive and eligible for test and treat. During
the study period, 44 more women who were originally
negative became HIV positive and became eligible giving
1106 (44 + 1062) women. Of the 1106, 321 HIV-positive
participants fully enrolled on “Test and Treat” of whom
293 (91.3%) who had complete records were included in
the analysis. Details are shown in the screening profile
(Fig. 1).
Baseline characteristics of women in the “test and treat”
programme
A total of 293 participants were included in the statis-
tical analysis. The mean (±SD) age of study participants
was 30.3 (± 6.5) years. Two hundred and fifty-five
(87.0%) had been tested for HIV before enrolment in
GHWP, 196(66.9%) were widowed or separated,
52(17.7%) were never married; 191(65.2%) were at WHO
clinical stage I; 75(25.6%) were at WHO clinical stage II.
One hundred ninety-seven (67.2%) participants reported
sex work as their current job. Those who reported no
sex work had other jobs including working in an enter-
tainment facility, a hotel/guest house or food vending;
3.1% reported being unemployed. The median baseline
CD4 (IQR) was 530 (348–757) cells/μl (Table 1).
Compared with those included in the analysis, those
who did not initiate ART at GHWP were not signifi-
cantly different in terms of highest level of education
attained. Furthermore, those included in the analysis
were older, a higher proportion were married, a lower
proportion reported sex work as their main job and had
fewer had a prior HIV test when compared to those who
did not initiate ART at GHWP. These were significantly
different (Table 1).
Lost to follow-up and associated factors
Of the 293 enrolled participants, 16% were LTFU within
the first year of ART initiation. The median follow-up
Fig. 1 Screening Profile of Study Participants
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time was 1.77 years, with the longest follow-up being 3.6
years. At the end of the follow-up period, three records
were censored due to known transfer out/shifted while
two were due to death. We recorded a total of 488.15
person-years of follow up, and the estimated LTFU rate
was 12.7 per 100 person-years (95% CI 9.90–16.3). Fig-
ure 2 illustrates the survival curve for the time to LTFU
after ART initiation during the follow-up period. Close
to 90% of the participants were still in care after 12
months of follow-up.
In the unadjusted analysis, LTFU was more likely
among those who reported sex work as their main job at
ART initiation compared to those who reported no sex
work (uHR 1.94; 95% CI 1.03–3.43), and those who had
baseline WHO clinical stage III or IV compared to those
who had baseline WHO clinical stage I (uHR 2.97; 95%
CI 1.50–5.86).
In the adjusted model, participants who reported sex
work as their current job at ART start were at a higher
risk of LTFU (aHR 1.95; 95%CI 1.10–3.45) while those
who had baseline WHO clinical stage III or IV were at
higher risk of LTFU (aHR 2.75; 95%CI 1.30–5.79)
compared to those who had baseline WHO clinical
stage I. (Table 2). The global test results showed p >
0.05 thus we do not have a violation of the proportional
assumption.
Table 1 Baseline sociodemographic and clinical characteristics of the 293 study participants enrolled in the Test and Treat
programme between August 2014 and March 2018 in Kampala Uganda
Characteristics Category Frequency
N = 293 n (col%)
Did not start ART at GHWP
N = 588 n (col%)
Chi-Square
P-value
Mean age (SD) 30.3 (6.5) 28.4 (6.1) < 0.001
Age at enrolment (year) < 25 50 (17.1) 178 (30) < 0.001
25–34 175 (59.7) 303 (52)
35+ 68 (23.2) 107 (18)
Marital Status Widowed/Separated 196 (66.9) 425 (72) < 0.001
Married 45 (15.4) 36 (6)
Never married 52 (17.7) 127 (22)
Current job No sex work 96 (32.8) 136 (23) 0.002
Sex worker 197 (67.2) 452 (77)
Highest formal education level attained No education 37 (12.6) 60 (10) 0.553
Attended Primary school 177 (60.4) 363 (62)
Secondary school or higher 79 (27.0) 165 (28)
Alcohol Consumption Patterns (AUDIT score)a Low risk 113 (38.6)
High risk 119 (40.6)
Dependent 61 (20.8)
Reported paid sex Yes 274 (93.5) 575 (98) 0.001
No 19 (6.5) 13 (2)
Year of ART starta 2014 15 (5.1)
2015 75 (25.6)
2016 130 (44.4)
2017 73 (24.9)
Baseline WHO stagea WHO Stage I 191 (65.2)
WHO Stage II 75 (25.6)
WHO Stage III & IV 27 (9.2)
Median CD4 count (IQR) 530 (348,757)
Baseline CD4 count (cells/μl)a Median (IQR) 0–350 74 (25.3)
Above 350 219 (74.7)
Ever tested for HIV before enrolling at the clinic Yes 255 (87) 560 (95) < 0.001
No 38 (13) 28 (5)
SD Standard deviation, IQR Interquartile range; AUDIT Scores: 0–7 Low Risk, 8–19 High risk, ≥20 Dependent; aNo available data for the comparison group
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Sensitivity analysis results
A sensitivity analysis by imputing data of participants who
had missing data on some covariates (n = 28) was done
and the results were similar to when they were excluded.
Discussion
In this study, we illustrate high rates of LTFU in a cohort
of early adopter, test and treat recipients of Ugandan
women at high risk of HIV-infection. Our study revealed
that the overall LTFU rate was 12.7 per 100 person-years.
The proportion of LTFU of 16% in the first year of ART
initiation in this study is high compared to the overall re-
sults of the meta analysis of attrition among FSWs that
was reported at 6% [24]. In studies carried out among
high-risk populations in coastal Kenya, high rates of LTFU
were found among men who have sex with men (MSM)
(14.5/100 PYAR) which is consistent with our study and
lower rates among women (10.4/100 PYAR) [25]. Other
studies carried out in the general population in sub-
Saharan Africa and elsewhere showed lower LTFU rates
ranging between 7.1–11.6 [18, 26, 27]. Some of the varia-
tions in the incidence rates might be explained by the dif-
ferences in the populations studied especially with those
in the general populations, as our study was carried out
among a high-risk population. For the studies carried out
in a similar population, the differences might be explained
by the follow-up strategies that are used to reach to these
participants [28].
Women who reported sex work as their current job at
the time of ART initiation were more likely to be LTFU
compared to those who reported other jobs. Studies car-
ried out in sub-Saharan Africa, the Caribbean and
elsewhere have found that FSWs are highly mobile and
because of this, it is hard for them to access secure
housing, supportive networks and regular income, this
makes it hard for them to start and stay on ART [24, 29,
30]. In the qualitative studies carried out among FSWs
seeking ART/general care services, major concerns were
rude remarks from providers, delay of services and po-
tential for breach of confidentiality [30, 31]. Although
we did not assess this, we assume that might explain
why some FSWs are likely to get lost after initiating
prompt ART. Many FSWs have a lifestyle which poses
barriers to stabilise on treatment such as high alcohol
intake, fear of being seen taking drugs which might re-
sult into losing their clients [32, 33].
There is a need to establish strategies targeting sex
workers to improve access to ART services conveniently
for example giving them special attention and according
them respect and continued assurance of confidentiality
when they come for drug refills and appointments. In
addition to the close monitoring and intensive follow-up
at the GHWP clinic, there is a need to have a sex worker-
supportive environment through community engagements
among FSWs so that universal access to HIV services and
acceptable ART delivery strategies can be identified [34].
In our study, we found that women who had baseline
clinical stage III or IV were more likely to get lost to
follow-up compared to those with baseline clinical stage I.
Our results are consistent with case-control studies that
were carried out in Uganda, Ethiopia and in another study
carried out in antiretroviral treatment (ART) clinics in
Tanzania, Uganda and Zambia to assess predictors of at-
trition [35–37]. Though we did not trace participants in
Fig. 2 Kaplan-Meier plot showing LTFU of participants during the follow-up period
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an advanced stage, studies done in SSA have shown that
this group tends to die early [38] . However, our results
contradict the findings of the study carried out in Ethiopia
in a general population which found out that clinical
WHO stage III was not associated with LTFU [39]. This
difference might be due to the difference in study settings
where this study in Ethiopia was carried out in govern-
mental health institutions (3 health centres and 2 Hospi-
tals) which provide ART service for the town and
surrounding population while our study was carried out in
a dedicated clinic that follows high risk women. Therefore,
this group needs to be targeted and encouraged to always
stay in care in order to achieve the 90–90-90 targets.
Study limitations
The main limitation is that we had 62 LTFU events from
our study, we believe a bigger study might have detected
further risk factors. We believe the fewer events might
affect our generalizability.
Another limitation was missing data on some of the
variables that were included in the analysis. Of the 321
that enrolled on “test and treat” at GHWP clinic, only
(91.3%; 293/321) had all the data available for analysis
on the selected variables. We however did the sensitivity
analysis which showed no differences in the results with
all the missing data imputed.
We used secondary data; some of the data that may in-
fluence the risk of LTFU such as social support were not
available. We believe such explanations would inform fu-
ture strategies of targeting groups of high-risk women
on ART. Notwithstanding these constraints, we believe
that our results will give an imperative understanding of
the magnitude and the factors associated with LTFU
among high-risk cohorts in the test and treat era.
Recommendation for further research
We recommend a qualitative research study among the
high-risk cohorts by exploring the barriers and challenges
Table 2 Multivariable analysis of predictors of Lost to follow-up among study participants enrolled in the Test and Treat programme
between August 2014 and March 2018 in Kampala Uganda
*significant at P < 0.05; HR Hazard Ratio, I Confidence Interval, LRT Likelihood Ratio Test, LTR Estimated LTFU rate per 100 person-years, uHR Unadjusted Hazard
Ratio, aHR Adjusted Hazard Ratio, Wald Wald Chi-square P-value; global test chi-square value = 6.90 and p-value = 0.548
Kamacooko et al. BMC Public Health          (2020) 20:353 Page 7 of 9
of this group in regard to LTFU. This should focus on
other behavioural characteristics.
Conclusion
Our findings report a high rate of lost to follow-up in
this cohort. Follow up strategies are required to support
women who initiate Test and Treat to, especially those
who engage in sex work as their main job and those who
initiate ART at a later stage of disease.
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